The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
The Hamster as a Model of Human Visceral Leishmaniasis: Progressive Disease and Impaired Generation of Nitric Oxide in the Face of a Prominent Th1-Like Cytokine Response
Open accessAbstract
Active human visceral leishmaniasis (VL) is characterized by a progressive increase in visceral parasite burden, cachexia, massive splenomegaly, and hypergammaglobulinemia. In contrast, mice infected with Leishmania donovani, the most commonly studied model of VL, do not develop overt, progressive disease. Furthermore, mice control Leishmania infection through the generation of NO, an effector mechanism that does not have a clear role in human macrophage antimicrobial function. Remarkably, infection of the Syrian hamster (Mesocricetus auratus) with L. donovani reproduced the clinicopathological features of human VL, and investigation into the mechanisms of disease in the hamster revealed striking differences from the murine model. Uncontrolled parasite replication in the hamster liver, spleen, and bone marrow occurred despite a strong Th1-like cytokine (IL-2, IFN-γ, and TNF/lymphotoxin) response in these organs, suggesting impairment of macrophage effector function. Indeed, throughout the course of infection, inducible NO synthase (iNOS, NOS2) mRNA or enzyme activity in liver or spleen tissue was not detected. In contrast, NOS2 mRNA and enzyme activity was readily detected in the spleens of infected mice. The impaired hamster NOS2 expression could not be explained by an absence of the NOS2 gene, overproduction of IL-4, defective TNF/lymphotoxin production (a potent second signal for NOS2 induction), or early dominant production of the deactivating cytokines IL-10 and TGF-β. Thus, although a Th1-like cytokine response was prominent, the major antileishmanial effector mechanism that is responsible for control of infection in mice was absent throughout the course of progressive VL in the hamster.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,566
Nitric oxide: A cytotoxic activated macrophage effector molecule
Hibbs, J. B., Taintor, R. R., Vavrin, Z., & Rachlin, E. M. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80015-9 · Cited by 2,030
Role of nitric oxide synthesis in macrophage antimicrobial activity
Nathan, C. F., & Hibbs, J. B. (1991) · Current Opinion in Immunology · doi:10.1016/0952-7915(91)90079-g · Cited by 1,523
Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., & Locksley, R. M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.59 · Cited by 1,454
Altered immune responses in mice lacking inducible nitric oxide synthase
Wei, X.-Q., Charles, I. G., Smith, A., Ure, J., Feng, G.-J., Huang, F.-P., Xu, D., Mullers, W., Moncada, S., & Liew, F. Y. (1995) · Nature · doi:10.1038/375408a0 · Cited by 1,292
Expression and secretion of type beta transforming growth factor by activated human macrophages.
Assoian, R. K., Fleurdelys, B. E., Stevenson, H. C., Miller, P. J., Madtes, D. K., Raines, E. W., Ross, R., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.17.6020 · Cited by 970
Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l -arginine.
Liew, F. Y., Millott, S., Parkinson, C., Palmer, R. M. J., & Moncada, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.12.4794 · Cited by 736
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
Tracey, K. J., Wei, H., Manogue, K. R., Fong, Y., Hesse, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., & Cerami, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.3.1211 · Cited by 730
IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages
Gazzinelli, R. T., Oswald, I. P., James, S. L., & Sher, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.6.1792 · Cited by 694
Green, S. J., Meltzer, M. S., Hibbs, J. B., & Nacy, C. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.1.278 · Cited by 675
Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta.
Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q. W., & Nathan, C. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.605 · Cited by 655
Liew, F. Y., Li, Y., & Millott, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4306 · Cited by 522
Ding, A., Nathan, C. F., Graycar, J., Derynck, R., Stuehr, D. J., & Srimal, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.3.940 · Cited by 500
Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.
Nicholson, S., Bonecini-Almeida, M. D. G., Lapa e Silva, J. R., Nathan, C., Xie, Q. W., Mumford, R., Weidner, J. R., Calaycay, J., Geng, J., Boechat, N., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2293 · Cited by 496
New Perspectives on a Subclinical Form of Visceral Leishmaniasis
Badaro, R., Jones, T. C., Carvalho, E. M., Sampaio, D., Reed, S. G., Barral, A., Teixeira, R., & Johnson, W. D. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.6.1003 · Cited by 480
Green, S. J., Crawford, R. M., Hockmeyer, J. T., Meltzer, M. S., & Nacy, C. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4290 · Cited by 456
Interleukin 10 production correlates with pathology in human Leishmania donovani infections.
Ghalib, H. W., Piuvezam, M. R., Skeiky, Y. A., Siddig, M., Hashim, F. A., el-Hassan, A. M., Russo, D. M., & Reed, S. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116570 · Cited by 434
Murray, H. W., & Nathan, C. F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.741 · Cited by 418
Chartrain, N. A., Geller, D. A., Koty, P. P., Sitrin, N. F., Nussler, A. K., Hoffman, E. P., Billiar, T. R., Hutchinson, N. I., & Mudgett, J. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37441-0 · Cited by 394
Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides.
Sakurai, H., Kohsaka, H., Liu, M. F., Higashiyama, H., Hirata, Y., Kanno, K., Saito, I., & Miyasaka, N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118292 · Cited by 387
Karp, C. L., el-Safi, S. H., Wynn, T. A., Satti, M. M., Kordofani, A. M., Hashim, F. A., Hag-Ali, M., Neva, F. A., Nutman, T. B., & Sacks, D. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116372 · Cited by 340
Schneemann, M., Schoedon, G., Hofer, S., Blau, N., Guerrero, L., & Schaffner, A. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1358 · Cited by 333
Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.
Carvalho, E. M., Badaró, R., Reed, S. G., Jones, T. C., & Johnson, W. D. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112209 · Cited by 315
Stenger, S., Thüring, H., Röllinghoff, M., & Bogdan, C. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.783 · Cited by 302
Vouldoukis, I., Bécherel, P., Riveros‐Moreno, V., Arock, M., Da Silva, O., Debré, P., Mazier, D., & Mossalayi, M. D. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270409 · Cited by 167
Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis.
Evans, T. G., Thai, L., Granger, D. L., & Hibbs, J. B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.2.907 · Cited by 150
Nelson, B. J., Ralph, P., Green, S. J., & Nacy, C. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.6.1849 · Cited by 147
Animal Models for the Analysis of Immune Responses to Leishmaniasis
Sacks, D. L., & Melby, P. C. (1998) · Current Protocols in Immunology · doi:10.1002/0471142735.im1902s28 · Cited by 135
Self-citationRole and effect of TNF- alpha in experimental visceral leishmaniasis.
Tumang, M. C., Keogh, C. V., Moldawer, L. L., HELFGOTT, D. C., Teitelbaum, R., Hariprashad, J., & Murray, H. W. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.2.768 · Cited by 133
Potential role for interleukin-10 in the immunosuppression associated with kala azar.
Holaday, B. J., Pompeu, M. M. D. L., Jerônimo, S. M. B., Texeira, M. J., Sousa, A., Vasconcelos, A. W., Pearson, R. D., Abrams, J. S., & Locksley, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116878 · Cited by 128
Splenic Cytokine Responses in Indian Kala‐Azar before and after Treatment
Kenney, R. T., Sacks, D. L., Gam, A. A., Murray, H. W., & Sundar, S. (1998) · The Journal of Infectious Diseases · doi:10.1086/517817 · Cited by 128
Li, J., Hunter, C. A., & Farrell, J. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.974 · Cited by 124
Expression of Inducible Nitric Oxide Synthase in Human Granulomas and Histiocytic Reactions
Facchetti, F., Vermi, W., Fiorentini, S., Chilosi, M., Caruso, A., Duse, M., Notarangelo, L. D., & Badolato, R. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65261-3 · Cited by 123
Melby, P. C., Yang, Y., Cheng, J., & Zhao, W. (1998) · Infection and Immunity · doi:10.1128/iai.66.1.18-27.1998 · Cited by 121
Self-citationLi, J., Hunter, C. A., & Farrell, J. P. (1999) · PubMed · Cited by 120
Zhang, X., Laubach, V. E., Alley, E. W., Edwards, K. A., Sherman, P. A., Russell, S. W., & Murphy, W. J. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.4.575 · Cited by 104
Endogenous Interleukin‐12 Regulates Acquired Resistance in Experimental Visceral Leishmaniasis
Murray, H. W. (1997) · The Journal of Infectious Diseases · doi:10.1086/516482 · Cited by 101
Transforming Growth Factor β and Immunosuppression in Experimental Visceral Leishmaniasis
Rodrigues, V., Silva, J. S., & Campos‐Neto, A. (1998) · Infection and Immunity · doi:10.1128/iai.66.3.1233-1236.1998 · Cited by 75
Chandrasekar, B., Melby, P. C., Troyer, D. A., et al. (1998) · PubMed · Cited by 74
Self-citationTheodos, C. M., Povinelli, L., Molina, R., Sherry, B. A., & Titus, R. G. (1991) · Infection and Immunity · doi:10.1128/iai.59.8.2839-2842.1991 · Cited by 66
Db, M., Ct, G., & Berde, C. B. (1992) · PubMed · Cited by 55
Chandrasekar, B., Melby, P. C., Troyer, D. A., & Freeman, G. L. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01258.x · Cited by 45
Self-citationThe complex regulation and biology of TNF (cachectin).
Beutler, B. (1990) · PubMed · Cited by 18
Cited by
Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?
Freitas-Junior, L. H., Chatelain, E., Kim, H. A., & Siqueira-Neto, J. L. (2012) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2012.01.003 · Cited by 294
Immunopathogenesis of infection with the visceralizing Leishmania species
Wilson, M. E., Jeronimo, S. M. B., & Pearson, R. D. (2005) · Microbial Pathogenesis · doi:10.1016/j.micpath.2004.11.002 · Cited by 281
Bhaumik, S. K., Paul, J., Naskar, K., Karmakar, S., & De, T. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr575 · Cited by 20
Metadata
- Authors
- Melby, P. C., Chandrasekar, B., Zhao, W., & Coe, J. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-02-01
- Volume
- 166
- Issue
- 3
- Pages
- 1912-1920
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2140056038
- Cited by
- 288
- References
- 44
- FWCI
- 9.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.